Operating cash flow changed across a low base
Operating cash flow changed -1114.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
-$803,000→-$9.8M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →HROW financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital changed across a sign change
Working capital changed +235.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
-$94.0M→$127.1M4 prior comparisons
Net income changed across a sign change
Net income changed -445.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
$5.0M→-$17.3M2 prior comparisons
Revenue increased 10.9%
Revenue changed +10.9% from the comparable as-filed period.
$63.7M→$70.7M2 prior comparisons
Total assets increased 20.8%
Total assets changed +20.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$345.0M→$416.8M4 prior comparisons
R&D / revenue moved 692 bp higher
R&D / revenue changed +692 basis points from the comparable as-filed period.
4.50%→11.42%2 prior comparisons
Stock-based compensation increased 332.9%
Stock-based compensation changed +332.9% from the comparable as-filed period.
$875,000→$3.8M2 prior comparisons
Capital expenditure increased 195.8%
Capital expenditure changed +195.8% from the comparable as-filed period.
$166,000→$491,0003 prior comparisons
Free-cash-flow margin moved 1298 bp lower
Free-cash-flow margin changed -1298 basis points from the comparable as-filed period.
-1.52%→-14.50%2 prior comparisons
Operating cash-flow margin moved 1255 bp lower
Operating cash-flow margin changed -1255 basis points from the comparable as-filed period.
-1.26%→-13.81%2 prior comparisons
Receivables / revenue moved 4413 bp higher
Receivables / revenue changed +4413 basis points from the comparable as-filed period.
123.66%→167.79%2 prior comparisons
Capex / revenue moved 43 bp higher
Capex / revenue changed +43 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.26%→0.69%2 prior comparisons
Shares outstanding increased 1.3%
Shares outstanding changed +1.3% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
37,002,136→37,487,8508 prior comparisons
Gross profit increased 6.0%
Gross profit changed +6.0% from the comparable as-filed period.
$47.5M→$50.4M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.